Clinical trials: The rise of IL-2 therapy-a novel biologic treatment for SLE

Jens Y. Humrich; Gabriela Riemekasten

doi:10.1038/nrrheum.2016.173

Clinical trials: The rise of IL-2 therapy-a novel biologic treatment for SLE

Jens Y. Humrich, Gabriela Riemekasten^*

^*Corresponding author for this work

Department of Rheumatology and Clinical Immunology

17 Citations (Scopus)

Original language	English
Journal	Nature Reviews Rheumatology
Volume	12
Issue number	12
Pages (from-to)	695-696
Number of pages	2
ISSN	1759-4790
DOIs	https://doi.org/10.1038/nrrheum.2016.173
Publication status	Published - 01.12.2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Access to Document

10.1038/nrrheum.2016.173

Cite this

@article{a740689e99a643a68e199ff1cc8b58f5,

title = "Clinical trials: The rise of IL-2 therapy-a novel biologic treatment for SLE",

author = "Humrich, \{Jens Y.\} and Gabriela Riemekasten",

year = "2016",

month = dec,

day = "1",

doi = "10.1038/nrrheum.2016.173",

language = "English",

volume = "12",

pages = "695--696",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",

publisher = "Nature Research",

number = "12",

}

TY - JOUR

T1 - Clinical trials: The rise of IL-2 therapy-a novel biologic treatment for SLE

AU - Humrich, Jens Y.

AU - Riemekasten, Gabriela

PY - 2016/12/1

Y1 - 2016/12/1

UR - https://www.scopus.com/pages/publications/84992110585

U2 - 10.1038/nrrheum.2016.173

DO - 10.1038/nrrheum.2016.173

M3 - Short survey

C2 - 27761021

AN - SCOPUS:84992110585

SN - 1759-4790

VL - 12

SP - 695

EP - 696

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 12

ER -

Clinical trials: The rise of IL-2 therapy-a novel biologic treatment for SLE

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Cite this